Results 241 to 250 of about 392,226 (299)

Bacterial Pigments as Potential Antitumor Agents Against Gastrointestinal Cancers: A Comprehensive Systematic Review

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Gastrointestinal cancers (GICs) constitute one of the leading causes of cancer‐related morbidity and mortality worldwide. Despite currently available therapeutic strategies, new approaches and procedures are needed for their prevention and treatment.
Raúl Vergara, Ricardo F. S. Pereira, Carla C. C. R. de Carvalho, Jose Prados, Consolación Melguizo, Raul Ortiz   +5 more
wiley   +1 more source

Novel Immune Checkpoint Inhibitor and Antibody-Drug Conjugate Approaches in the Perioperative Management of Muscle-Invasive Bladder Cancer. [PDF]

Curr Oncol
Vento J, Zhang T, Lotan Y, Woldu S, Qin Q.   +4 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Long-term recurrence-free survival following total penectomy and additional chemotherapy for solitary penile metastasis from muscle invasive bladder cancer. [PDF]

Urol Case Rep
Ishikawa D, Naiki T, Naiki-Ito A, Suzuki H, Tsubouchi Y, Shimizu N, Morikawa T, Aoki M, Gonda M, Kawai N, Umemoto Y, Yasui T.   +11 more
europepmc   +1 more source

Completion vs. early discontinuation of chemotherapy and the impact on 5‐year all‐cause mortality in women treated for early‐stage breast cancer from 2015 to 2020: A cohort study using a target trial emulation approach

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Chemotherapy is given for early‐stage breast cancer; however, some patients discontinue before completing all planned cycles. This study investigated the impact of early chemotherapy discontinuation on treatment outcomes. Methods This retrospective cohort study used a target trial emulation framework to conduct a causal analysis of the all‐
Luke Steventon, Chengsheng Ju, Kenneth K. C. Man, Rebecca Roylance, Diego Ottaviani, Chiara Creed, Michal Sladkowski, Alec Wisner, Li Wei, Pinkie Chambers   +9 more
wiley   +1 more source

The impact of the COVID-19 pandemic on breast cancer screening, treatment, and overall survival. [PDF]

Breast Cancer Res Treat
Decker KM, Feely A, Pitz M, Hebbard P, Kim JO, Czaykowski P, Singh H, Bucher O, Musto G, Lambert P.   +9 more
europepmc   +1 more source

Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer. [PDF]

Breast Cancer (Dove Med Press)
Chen HH, Chang SJ, Kan JY, Chen FM, Li CL, Takahashi H, Shih SL, Hou MF, Pan MR, Yang PF, Luo CW.   +10 more
europepmc   +1 more source

Tumor-Infiltrating Immune Cells Are More Abundant in Lung Metastases From Colorectal Cancer Than in Paired Primary Tumors and Their Prognostic Value Depends on Adjuvant Chemotherapy. [PDF]

Cancer Med
Kuznyecov D, Siesing C, Vidarsdottir H, Eberhard J, Brunnström H, Leandersson K, Jirström K.   +6 more
europepmc   +1 more source

Trends in the management and prognosis of mucinous borderline ovarian tumors: analysis of 12,766 cases from the JSOG Gynecologic Tumor Registry (2004-2018). [PDF]

Int J Clin Oncol
Tokunaga H, Shibuya Y, Yamagami W, Takahashi F, Yamamoto E, Yokoyama Y, Yoshino K, Kawana K, Nagase S.   +8 more
europepmc   +1 more source